| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.01 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |